Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.8B | 2.0B | 1.9B | 2.1B |
Cost of revenue | 1.6B | 1.7B | 1.6B | 1.8B |
Gross profit | 262.8M | 288.0M | 257.1M | 293.0M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 199.9M | 229.0M | 197.2M | 200.0M |
Other operating expenses | -16.6M | -18.4M | -15.2M | -18.5M |
Operating income | 79.5M | 77.5M | 75.1M | 111.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 12.0M | 12.1M | 11.8M | 12.2M |
Other income expense | 4.6M | 4.3M | 10.5M | 11.2M |
Pretax income | 72.1M | 69.7M | 73.8M | 110.5M |
Tax provision | 14.3M | 56.0M | 20.0M | 13.0M |
Net income | 57.8M | 13.6M | 53.8M | 97.5M |
Basic EPS | 0.0 | — | 0.0 | 0.0 |
Diluted EPS | 0.0 | — | 0.0 | 0.0 |
Basic average shares | 3.0B | — | 2.7B | 2.7B |
Diluted average shares | 3.0B | — | 2.7B | 2.7B |
EBITDA | 229.7M | 232.5M | 219.6M | 261.0M |
Net income from continuing op. | 72.1M | 69.7M | 73.8M | 110.5M |
Minority interests | 2.9M | 2.2M | -1.1M | -544K |
Preferred stock dividends | — | — | — | — |